Literature DB >> 21326260

What to expect from the Pharmacogenomics Research Network.

R M Long1, J M Berg.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21326260     DOI： 10.1038/clpt.2010.293

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

1.  Evolving research and stakeholder perspectives on pharmacogenomics.

Authors:  Amber L Beitelshees; David L Veenstra
Journal:  JAMA       Date:  2011-09-21       Impact factor: 56.272

2.  Molecular clinical biochemistry in laboratory medicine: the present and the future.

Authors:  A R Aroor
Journal:  Indian J Clin Biochem       Date:  2011-05-10

3.  Harmonization and semantic annotation of data dictionaries from the Pharmacogenomics Research Network: a case study.

Authors:  Qian Zhu; Robert R Freimuth; Zonghui Lian; Scott Bauer; Jyotishman Pathak; Cui Tao; Matthew J Durski; Christopher G Chute
Journal:  J Biomed Inform       Date:  2012-11-29       Impact factor: 6.317

4.  Semi-supervised Learning for Phenotyping Tasks.

Authors:  Dmitriy Dligach; Timothy Miller; Guergana K Savova
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

5.  Normalization and standardization of electronic health records for high-throughput phenotyping: the SHARPn consortium.

Authors:  Jyotishman Pathak; Kent R Bailey; Calvin E Beebe; Steven Bethard; David C Carrell; Pei J Chen; Dmitriy Dligach; Cory M Endle; Lacey A Hart; Peter J Haug; Stanley M Huff; Vinod C Kaggal; Dingcheng Li; Hongfang Liu; Kyle Marchant; James Masanz; Timothy Miller; Thomas A Oniki; Martha Palmer; Kevin J Peterson; Susan Rea; Guergana K Savova; Craig R Stancl; Sunghwan Sohn; Harold R Solbrig; Dale B Suesse; Cui Tao; David P Taylor; Les Westberg; Stephen Wu; Ning Zhuo; Christopher G Chute
Journal:  J Am Med Inform Assoc       Date:  2013-11-04       Impact factor: 4.497
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.